Physician profile
Mehul B Patel
NPI 1003097593
$382,373.64
in general payments reported to CMS, 2019-2025
16 companies · $93K in 2025
The $93K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37K · 2020: $37K · 2021: $41K · 2022: $95K · 2023: $35K · 2024: $45K · 2025: $93K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $81K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $44K · Travel and Lodging: $41K · Food and Beverage: $6,686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $81,307.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $44,250.00 |
| Travel and Lodging | $41,039.65 |
| Food and Beverage | $6,685.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $272,227.30 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $36,477.23 | 2019-2025 | Watchman Access System, General - Therapies, Rotapro |
| Medtronic, INC. | $35,203.28 | 2021-2025 | Corevalve Evolut R, Harmony, Symplicity G3 |
| Medtronic Vascular, INC. | $19,530.02 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $10,617.15 | 2024-2025 | Gore Cardioform Septal Occluder, Gore Cardioform Asd Occluder, Product In Development |
| Abbott Laboratories | $5,451.81 | 2019-2025 | Mitraclip, Amplatzer Amulet, Triclip |
| Medical Device Business Services, INC. | $2,058.39 | 2023-2024 | Carto 3 |
| Penumbra, INC. | $275.48 | 2025 | Indigo System |
| Ge Healthcare | $210.00 | 2019 | |
| Stryker Corporation | $116.83 | 2019 | |
| Philips North America LLC | $72.62 | 2019-2022 | |
| Resmed Corp | $35.35 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.26 | 2023-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $31.72 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $20.41 | 2025 | Farxiga |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $11.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mehul Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.